The search found 3759 results.
News
Secure text messaging isn't only helping to expedite patient care and caregiver response at a South Carolina hospital, it's boosting staff efficiency and enabling treatment interaction by caregivers who live in remote areas with unreliable cell coverage.
Datasheet
Electronic Prescribing of Controlled Substances (EPCS) can help in achieving Meaningful Use (MU) requirements for e-prescribing. E-prescribing is a core measure of MU. Enabling EPCS increases organizations’ e-prescribing ratios by eliminating dual workflows and allows for a single, streamlined prescription workflow. MU e-prescribing requirements are going to become more stringent in the future so enabling EPCS today is a strategic step to future success. Imprivata Confirm ID™ is a fast, secure signing solution for enabling EPCS.
Datasheet
Electronic Prescribing of Controlled Substances (EPCS) can help curb DEA number theft and protect against fraudulent prescription practices. EPCS is more secure than paper prescriptions. With EPCS, prescriptions are automatically sent to patients’ pharmacies without patients ever seeing their doctors’ DEA number printed on their scripts. Imprivata Confirm ID™ is a fast, secure signing solution for enabling EPCS.
Datasheet
Electronic Prescribing of Controlled Substances (EPCS) can eliminate dual prescribing workflows and enhance patient satisfaction. Without EPCS, prescribers are tasked to complete two different prescribing processes creating an inefficient and confusing prescribing workflow for both the prescriber and patient. Patients are often prescribed a mix of paper and electronic prescriptions creating patient dissatisfaction. By enabling EPCS with Imprivata Confirm ID™ all prescribing is streamlined into a single, secure workflow.
Datasheet
Electronic Prescribing of Controlled Substances (EPCS) can help tackle one of the most serious epidemics in the US today: prescription drug abuse. Twice as many deaths result from prescription drug overdose than from cocaine and heroin overdoses combined. In 2010, with almost 50 percent of all substance abuse deaths related to prescription drug overdose, the DEA responded by finalizing a rule allowing electronic prescribing of controlled substances (EPCS).
Whitepaper
The DEA Interim Final Rule (IFR) allowing EPCS is designed to reduce drug diversion and fraud by ensuring providers are legally authorized to prescribe controlled substances and they use proper authentication methods to sign orders. This paper describes how Imprivata Confirm ID addresses several DEA requirements for EPCS, including provider identity proofing, two-factor authentication, and auditing.
Press
Imprivata Confirm ID, the First Comprehensive Product that Simplifies Adoption of Regulatory Requirements for EPCS, Helps Providers Address Inefficiencies and Potential Fraud Caused by Paper-Based Prescriptions